The information on this page is current as of Mar 22, 2024.
For the most up-to-date version of CFR Title 21, go to the Electronic Code of Federal Regulations (eCFR).
[Code of Federal Regulations] |
[Title 21, Volume 5] |
[CITE: 21CFR312.52] |
TITLE 21--FOOD AND DRUGS |
CHAPTER I--FOOD AND DRUG ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES |
SUBCHAPTER D - DRUGS FOR HUMAN USE |
Subpart D - Responsibilities of Sponsors and Investigators
Sec. 312.52 Transfer of obligations to a contract research organization. |
(a) A sponsor may transfer responsibility for any or all of the obligations set forth in this part to a contract research organization. Any such transfer shall be described in writing. If not all obligations are transferred, the writing is required to describe each of the obligations being assumed by the contract research organization. If all obligations are transferred, a general statement that all obligations have been transferred is acceptable. Any obligation not covered by the written description shall be deemed not to have been transferred.
(b) A contract research organization that assumes any obligation of a sponsor shall comply with the specific regulations in this chapter applicable to this obligation and shall be subject to the same regulatory action as a sponsor for failure to comply with any obligation assumed under these regulations. Thus, all references to "sponsor" in this part apply to a contract research organization to the extent that it assumes one or more obligations of the sponsor.
This website has been translated to Spanish from English, and is updated often. It is possible that some links will connect you to content only available in English or some of the words on the page will appear in English until translation has been completed (usually within 24 hours). We appreciate your patience with the translation process. In the case of any discrepancy in meaning, the English version is considered official. Thank you for visiting esp.fda.gov/tabaco.
Page Last Updated: 03/22/2024